Literature DB >> 6893343

Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine.

A Y Zvonarjev, Y Z Ghendon.   

Abstract

The transcriptase activity of influenza A virus ribonucleoproteins was inhibited by 42 to 49% in vitro in the presence of membrane (M) protein. The addition of M protein to the system of ribonucleoprotein preparations isolated from rimantadine-sensitive or rimantadine-resistant influenza virus strains, as well as the addition of M protein isolated from a sensitive strain, in the presence of rimantadine further inhibited the transcriptase activity of such complexes by approximately 40%. In the system containing the same ribonucleoprotein preparations, but with M protein isolated from a rimantadine-resistant influenza virus strain, the transcriptase activity was not sensitive to rimantadine. The data show that M protein can influence the activity of influenza A virus virion transcriptase and that the susceptibility of influenza virus to rimantadine may be due to the peculiarities of M protein.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6893343      PMCID: PMC288582     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Influenza virion RNA-dependent RNA polymerase: stimulation by guanosine and related compounds.

Authors:  D McGeoch; N Kitron
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

2.  Effect of adamantane derivatives on the activity of orthomyxovirus RNA-dependent RNA polymerase.

Authors:  V A Kalninya; M K Indulen
Journal:  Acta Virol       Date:  1976-08       Impact factor: 1.162

3.  Electron microscopic observations on the entry of influenza virus into susceptible cells.

Authors:  R R Dourmashkin; D A Tyrrell
Journal:  J Gen Virol       Date:  1974-07       Impact factor: 3.891

4.  The membrane protein of influenza virus: extraction from virus and infected cell with acidic chloroform-methanol.

Authors:  A Gregoriades
Journal:  Virology       Date:  1973-08       Impact factor: 3.616

5.  Inhibition of uncoating of fowl plague virus by l-adamantanamine hydrochloride.

Authors:  N Kato; H J Eggers
Journal:  Virology       Date:  1969-04       Impact factor: 3.616

6.  Study on the mechanism of inhibiting action of aminoadamantane on the reproduction of fowl plague virus.

Authors:  M K Indulen; V A Kalninya
Journal:  Acta Virol       Date:  1973-07       Impact factor: 1.162

7.  Newcastle disease virus RNA. I. Isolation and preliminary characterization of RNA from virus particles.

Authors:  D W Kingsbury
Journal:  J Mol Biol       Date:  1966-06       Impact factor: 5.469

8.  Transcription of the influenza ribonucleic acid genome by a virion polymerase. I. Optimal conditions for in vitro activity of the ribonucleic acid-dependent ribonucleic acid polymerase.

Authors:  D H Bishop; J F Obijeski; R W Simpson
Journal:  J Virol       Date:  1971-07       Impact factor: 5.103

9.  On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride.

Authors:  J J Skehel; A J Hay; J A Armstrong
Journal:  J Gen Virol       Date:  1978-01       Impact factor: 3.891

10.  Identification of the defective genes in three mutant groups of influenza virus.

Authors:  M B Ritchey; P Palese
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

View more
  43 in total

1.  Influenza virus matrix protein is the major driving force in virus budding.

Authors:  P Gómez-Puertas; C Albo; E Pérez-Pastrana; A Vivo; A Portela
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Modeling the intracellular dynamics of influenza virus replication to understand the control of viral RNA synthesis.

Authors:  Frank S Heldt; Timo Frensing; Udo Reichl
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription.

Authors:  Thorsten Reuter; Benedikt Weissbrich; Sibylle Schneider-Schaulies; Jürgen Schneider-Schaulies
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Structure-based design of NS2 mutants for attenuated influenza A virus vaccines.

Authors:  Hatice Akarsu; Kiyoko Iwatsuki-Horimoto; Takeshi Noda; Eiryo Kawakami; Hiroaki Katsura; Florence Baudin; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  Virus Res       Date:  2010-10-21       Impact factor: 3.303

5.  Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity.

Authors:  D A Simpson; R A Lamb
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

6.  Monoclonal antibodies to the M protein of vesicular stomatitis virus (Indiana serotype) and to a cDNA M gene expression product.

Authors:  R Pal; B W Grinnell; R M Snyder; J R Wiener; W A Volk; R R Wagner
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

7.  Borna disease virus matrix protein is an integral component of the viral ribonucleoprotein complex that does not interfere with polymerase activity.

Authors:  Geoffrey Chase; Daniel Mayer; Antonia Hildebrand; Ronald Frank; Yohei Hayashi; Keizo Tomonaga; Martin Schwemmle
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Rabies virus M protein expressed in Escherichia coli and its regulatory role in virion-associated transcriptase activity.

Authors:  Y Ito; A Nishizono; K Mannen; K Hiramatsu; K Mifune
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  M protein (M1) of influenza virus: antigenic analysis and intracellular localization with monoclonal antibodies.

Authors:  D Bucher; S Popple; M Baer; A Mikhail; Y F Gong; C Whitaker; E Paoletti; A Judd
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

10.  Serine 3 is critical for phosphorylation at the N-terminal end of the nucleoprotein of influenza virus A/Victoria/3/75.

Authors:  M Arrese; A Portela
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.